Summary
CD26 antigen distribution among lymphoid and non lymphoid cells is widely documented. This antigen contains dipeptidyl peptidase IV (DPP-IV) enzymatic activity and it is thought to play an important role in the processes of cellular activation. We show that cell activation through the CD26 pathway induces DNA binding of the NF-κB/rel family of transcription factors in human peripheral T lymphocytes, in the hepatoma cell line HepG2, and in Hela cells. The functional significance of the NF-κB in the CD26 mediated signal transduction pathway is demonstrated by transient transfection analysis, since treatment of HepG2 and Hela cells with the anti-CD26 monoclonal antibodies 134-2C2 and 1F7 resulted in transactivation of a luciferase reported construct driven by three κB sites. The ability of CD26 to activate NF-κB seems to be independent of its DPP-IV activity but it is likely that CD26 activation results in an increase of intracellular levels of reactive oxygen intermediates as deduced from the antioxidant pyrrolidine dithiocarbamate blocking of the induction of NF-κB activity on CD26 activated cells. These results provide new evidence that the CD26 antigen plays a pivotal role in the mechanisms of activation of CD26 expressing cells.
Similar content being viewed by others
References
Baeuerle PA, Henkel T (1994) Function and activation of NF-Kappa-B in the immune system. Annu Rev Immunol 12: 141–179
Baur A, Garber S, Peterlin BM (1994) Effect of CD45 on NF-κB. J Immunol 152: 976–982
Bauvois B (1988) A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV. Biochem J 252: 723–731
Bose HR Jr (1992) The Rel family: models for transcriptional regulation and oncogenic transformation. Biochim Biophys Acta 1114: 1–17
Buc HA, Moncion A, Hamet M, Houllier AM, Thuilier L, Perignon JL (1990) Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation. Eur J Immunol 20: 611–616
Buhling F, Junker U, Reinhold D, Neubert K, Jager L, Ansorge S (1995) Functional role of CD26 on human B-lymphocytes. Immunol Lett 45: 47–51
Chen JZ, Parent L, Maniatis T (1996) Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853–862
Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C (1990a) Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CDS and CD2 pathways. J Immunol 144: 4092–4100
— —, Sugita K, Daley JF, Schow P, Prado C, Schlossman SF, Morimoto C (1990b) Cell surface modulation of CD26 by anti-1F7 monoclonal antibody: analysis of surface expression and human T cell activation. J Immunol 145: 3963–3971
Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A, Trugnan G (1992) Dipeptidyl peptidase IV (CD26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. J Biol Chem 267: 4824–4833
Dirjens WNM, ten Kate J, van der Linden EP, Wijnen JT, Khan PM, Bosman FT (1989) Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. J Histochem Cytochem 37: 1869–1876
Finco TS, Baldwin AS Jr (1995) Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263–272
Fleischer B (1987) A novel pathway of human cell activation via a 103 KD T cell activation antigen. J Immunol 138: 1346–1350
— (1994) CD26: a surface protease involved in T-cell activation. Immunol Today 15: 180–184
—, Sturm E, de Vries JE, Spits H (1988) Triggering of cytotoxic T lymphocytes and NK cells via the Tp 103 pathway is dependent on the expression of the T cell receptor/CD3 complex. J Immunol 141: 1103–1107
Hafler DA, Chofflon M, Benjamin D, Dang DH, Breitmeyer J (1989) T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression. J Immunol 142: 2590–2596
Hegen M, Mittrucker HW, Hugh R, Demuth HU, Neubert K, Barth A, Fleischer B (1993) Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signaling function in T cells. Immunobiology 189: 483–493
Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Heriah Y, Baeuerle PA (1993) Rapid proteolysis of I-kappa-B-alpha is necessary for activation of transcription factor NF-kappa-B. Nature 365: 182–185
Israël A (1995) A role for phosphorylation and degradation in the controls of NF-kappa-B activity. Trends Genet 11: 203–205
Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261: 466–469
Kieran M, Blank V, Logeat F, Vanderkerckhove J, Lottspeich F, LeBail O, Urban MB, Kourilsky P, Baeuerle PA, Israël A (1990) The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62: 1007–1018
Kitajima I, Shinohara TJ, Bilakovics J, Brown DA, Xu X, Nerenberg M (1992) Ablation of transplanted HTLV-I Tax transformed tumors in mice by antisense inhibition of NF-κB. Science 258: 1792–1795
Lau KHW, Farley JR, Baylink DJ (1989) Phosphotyrosine protein phosphatases. Biochem J 257: 23–31
McCaughan GW, Wickson JE, Creswick PF, Gorrell MD (1990) Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence. Hepatology 11: 534–539
Madueño JA, Muñoz E, Blazquez V, Gonzalez R, Aparicio P, Peña J (1993) The CD26 antigen is coupled to protein tyrosine phosphorylation and implicated in CD16-mediated lysis in natural killer cells. Scand J Immunol 37: 425–429
Martin M, Huguet J, Centelle JJ, Franco R (1995) Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol 155: 4630–4643
Meyer M, Schreck R, Baeuerle PA (1993) H2O2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005–2015
Morimoto C, Torimoto Y, Levinson G, Rudd CE, Schrieber M, Dang NH, Letvin NL, Schlossman SF (1989) 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol 143: 3430–3439
Muñoz E, Blázquez MV, Madueno JA, Rubio G, Peña J (1992) CD26 induces T-cell proliferation by tyrosine protein phosphorylation. Immunology 77: 43–50
Nagatsu T, Hino M, Fuyamda H, Hayakawa T, Sakakibara S, Nakagawa Y, Takemoto T (1976) New chromogenic substrates for X-prolyl dipeptide-aminopeptidase. Anal Biochem 74: 466–476
Narayanan R, Klement JF, Rubens SM, Higgins KA, Rosen CA (1993) Identification of a naturally occurring transforming variant of the p65 subunit of NF-Kappa-B. Science 256: 367–370
Neri A, Chang CC, Lombardi L, Dalina M, Corradini P, Maiolo AT, Chaganti RSK, Dalla-Favera R (1991) B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 67: 1075–1087
Pahl HL, Baeuerle PA (1996) Control of gene expression by proteolysis. Curr Opin Cell Biol 8: 340–347
Piazza G, Callanan HM, Mowery J, Hixson DC (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interaction of hepatocytes with extracellular matrix. J Biochem 262: 327–334
Reinhold D, Bank U, Buhling F, Kahne T, Kunt D, Faust J, Neubert K, Ansorge S (1994) Inhibitors of dipeptidyl peptidase IV (DP-IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology 192: 121–136
Rice NR, Mackichan ML, Israel A (1992) The precursor of NF-kappaB p50 has IkappaB-like functions. Cell 71: 243–253
Riemann D, Kehlen A, Langner J (1995) Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T-cell derived cytokines, such as IL-4 and IL-13. Clin Exp Immunol 100: 277–283
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messenger in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247–2258
Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705–714
Steeg C, Hartwig U, Fleischer B (1995) Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity. Cell Immunol 164: 311–315
Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman ST, Morimoto C (1992) Cloning and functional expression of the T cell activation antigen CD26. J Immunol 149: 481–486
—, Kameoka J, Yaron A, Schlossman SF, Morimoto C (1993) The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90: 4586–4590
—, Umeki K, Yamamoto I, Sakamoto F, Noguchi S, Ohtaki S (1995) CD26 (dipeptidyl peptidase IV) as a novel marker for differentiated thyroid carcinoma. Int J Cancer 64: 326–331
Thakur S, Lin HC, Tseng WT, Kumar S, Bravo R, Foss F, Gélinas C, Rabson AB (1994) Rearrangement and altered expression of the NF-KB-2 gene in human cutaneous T-lymphoma cells. Oncogene 9: 2335–2344
Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C (1991) Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 147: 2514–2517
Traenckner EB-M, Wilk S, Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB. EMBO J 13: 5433–5441
Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9: 2723–2735
Yoshioka M, Erickson RH, Matsumoto H, Gum E, Kim YS (1991) Expression of dipeptidyl aminopeptidase IV during enterocytic differentiation of human colon cancer (CACO-2) cells. Int J Cancer 47: 916–921
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blàzquez, M.V., Ortiz, C., Aranda, E. et al. NF-κB activation by CD26 antigen is independent of dipeptidyl peptidase IV activity. Protoplasma 197, 26–33 (1997). https://doi.org/10.1007/BF01279881
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01279881